Evidence map›Paper›PMID 31720389›Full record

ReviewJournal of clinical tuberculosis and other mycobacterial diseases2018

Tuberculosis prevention and care in Korea: Evolution of policy and practice.

Unyeong Go, Misun Park, Un-Na Kim, Sodam Lee, Sunmi Han, Joosun Lee, Jiyeon Yang, Jieun Kim, Shinyoung Park, Youngman Kim and 20 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical tuberculosis and other mycobacterial diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 1 institution in 1 country.

Unyeong GoCenter for Disease Prevention, Korean Network for Organ Sharing, Korea Centers for Disease Control and Prevention, Republic of Korea.
Misun ParkDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Un-Na KimDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Sodam LeeDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Sunmi HanDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Joosun LeeDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Jiyeon YangDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Jieun KimDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Shinyoung ParkDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Youngman KimDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Hyosoon YooDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Jeongok ChaDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Wonseo ParkDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Haeyoung KangDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Hwon KimDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Guri ParkDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Minjung KimDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Ok ParkDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Hyunjin SonDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Enhi ChoDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Kyoungin NaDivision of TB and HIV/AIDS Control, Korea Centers for Disease Control and Prevention, Republic of Korea.
Yunhyung KwonDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Yeonkyeng LeeDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Kang Hee LeeDivision of TB Investigation, Korea Centers for Disease Control and Prevention, Republic of Korea.
Eunkyeong JeongCenter for Disease Prevention, Korean Network for Organ Sharing, Korea Centers for Disease Control and Prevention, Republic of Korea.
Dukhyoung LeeKorea Centers for Disease Control and Prevention, Republic of Korea.
Byung-Guk YangKorea Centers for Disease Control and Prevention, Republic of Korea.
Byung-Yul JeonKorea Centers for Disease Control and Prevention, Republic of Korea.
Jong-Koo LeeKorea Centers for Disease Control and Prevention, Republic of Korea.
Korea Tuberculosis Epidemic Investigation Service
Korea Disease Control and Prevention Agency · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) in Korea remains a serious health problem with an estimated 77 per 100,000 incidence rate for 2016. This makes Korea as the only OECD country with high incidence of TB. The government has increased budgets and strengthened patient management policies since 2011. The management of latent tuberculosis was added to the response with strengthened and extensive contact investigations in the five-year tuberculosis control plan (2013-2017) and implementation was established in 2013. Due to these efforts Korea has achieved an average 5.2% reduction annually in tuberculosis incidence rate between 2011 and 2016. To further expedite the reduction of the TB burden the government has introduced additional measures including mandatory screening of latent tuberculosis infection for community workers in congregate settings including daycare centers for children, kindergarten, and teachers in schools and health care workers in clinics and hospitals to solve the problems identified through contact investigations in 2017. Providing high quality free diagnosis and treatment of active TB including for multidrug resistant TB combined with active contact investigations is the mainstay of the current programmatic response in Korea. However, the limitation of existing tools for LTBI pose challenge including absence of best mechanism for effective communication with professionals and the public, the need for at least 3 months of treatment and the risk of side effects. Developing effective tools will help to overcome these challenges.

Indexed as

Contact investigationsEnd TBEpidemiologyLatent tuberculosis infectionTuberculosis

Identifiers

PMID31720389
PMCPMC6830170
OpenAlexW2797177934

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.